Summary
This prediction is currently active. The prediction for Altimmune disappoints with a performance of -23.77%. This prediction currently runs until 18.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Altimmune | -8.200% | -8.200% |
| iShares Core DAX® | -2,49 % | 0,32 % |
| iShares Nasdaq 100 | -4,40 % | 1,59 % |
| iShares Nikkei 225® | -4,29 % | 0,97 % |
| iShares S&P 500 | -2,20 % | 2,00 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Altimmune diskutieren
Altimmune (ALT) is now covered by Truist Financial Corporation. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for ALT provided by MarketBeat